A Clinical Performance of Two Soft Toric Contact Lenses

NCT05633082 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2023-11-07

Study results available
· View outcomes & findings →

Summary

The study objective was to gather short-term clinical performance data for two soft toric contact lenses.

Conditions

  • Astigmatism

Interventions

DEVICE

Lens 1 (omafilcon B)

Toric daily wear contact lens for 15 minutes

DEVICE

Lens 2 (fanfilcon A)

Toric daily wear contact lens for 15 minutes

Sponsors & Collaborators

  • CooperVision, Inc.

    lead INDUSTRY

Principal Investigators

  • Philip Morgan, PhD, MCOptom · Eurolens Research

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-21
Primary Completion
2022-09-30
Completion
2022-09-30
FDA Device
Yes

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05633082 on ClinicalTrials.gov